ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,838Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 910

$638K Total Retail Price of All Prescriptions

Rank: 94 out of 910

812 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 812 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 812 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 468 379 1 1
LISINOPRIL 366 279 2 2
OMEPRAZOLE 350 248 3 5
FUROSEMIDE 329 286 4 9
SIMVASTATIN 321 259 5 3
HYDROCODONE-ACETAMINOPHEN 302 209 S3 6 8
METFORMIN HCL 249 168 7 6
GABAPENTIN 235 161 8 13
AMLODIPINE BESYLATE 228 191 9 4
ZOLPIDEM TARTRATE 202 160 10 17
POTASSIUM CHLORIDE 175 140 11 18
METOPROLOL TARTRATE 172 161 12 7
HYDROCHLOROTHIAZIDE 166 140 13 12
ATENOLOL 166 149 13 10
SERTRALINE HCL 139 95 15 24
WARFARIN SODIUM 130 97 16 11
ATORVASTATIN CALCIUM 118 101 17 14
TRAZODONE HCL 118 85 17 37
AZITHROMYCIN 117 82 19 41
OXYCODONE HCL 114 59 S2 20 42
CITALOPRAM HBR 110 67 21 19
GLIPIZIDE 110 73 21 38
DONEPEZIL HCL 104 104 23 32
FLUOXETINE HCL 102 67 24 49
DIOVAN 100 84 25 34
CLOPIDOGREL 96 80 26 35
LANTUS 91 59 27 30
FLUTICASONE PROPIONATE 89 42 28 23
PREDNISONE 88 64 29 43
CARVEDILOL 88 74 29 36
TAMSULOSIN HCL 82 72 31 29
LOVASTATIN 82 80 31 20
ALLOPURINOL 80 63 33 33
MORPHINE SULFATE ER 72 27 S2 34 52
MORPHINE SULFATE 72 21 S2 34 156
METOPROLOL SUCCINATE 72 64 34 21
AMITRIPTYLINE HCL 70 25 R 37 72
OXYCODONE-ACETAMINOPHEN 69 29 S2 38 31
LYRICA 68 41 39 131
HUMALOG 67 33 40 128
PAROXETINE HCL 66 65 41 50
CARISOPRODOL 65 35 R 42 71
GEMFIBROZIL 65 39 42 63
RANITIDINE HCL 64 43 44 28
NAMENDA 62 51 45 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 47 46 134
PRAVASTATIN SODIUM 59 37 46 16
CELEBREX 59 37 46 85
PLAVIX 59 53 46 53
PROAIR HFA 56 26 50 40
TRAMADOL HCL 56 30 50 25
DEXILANT 54 43 52 273
PREMARIN 53 30 R 53 127
CIPROFLOXACIN HCL 53 38 53 48
ADVAIR DISKUS 53 42 53 45
MELOXICAM 52 48 56 76
DIGOXIN 52 52 56 64
OXYCODONE HCL-ACETAMINOPHEN 51 16 S2 58 114
QUETIAPINE FUMARATE 51 44 58 70
PROMETHAZINE HCL 50 0 R 60 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.